Cellular and molecular basis of the imbalance between vascular damage and repair in ageing and age-related diseases: As biomarkers and targets for new treatments

Mechanisms of Ageing and Development

Volumn 159, Issue , 2016, Pages 22-30

  Madonna, Rosalinda ^a   Novo, Giuseppina ^b   Balistreri, Carmela Rita ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Ageing; Biomarkers; Stem and progenitor cells; Vascular disease

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 6; CD133 ANTIGEN; CD14 ANTIGEN; CD146 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ENDOGLIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NOTCH RECEPTOR; REACTIVE OXYGEN METABOLITE; STEM CELL ANTIGEN 1; STROMAL CELL DERIVED FACTOR 1; TIE 1 RECEPTOR; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; WNT PROTEIN; TUMOR MARKER;

AGING; ARTICLE; CARDIAC MYOBLAST; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELL REGENERATION; CELL SURVIVAL; DISEASE COURSE; ENDOTHELIAL PROGENITOR CELL; FETUS CELL; HUMAN; INDUCED PLURIPOTENT STEM CELL; MESENCHYMAL STEM CELL; MUSCLE STEM CELL; MYOFIBROBLAST; NONHUMAN; PERICYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; SKELETAL MYOBLAST; SMOOTH MUSCLE PROGENITOR CELL; UMBILICAL CORD BLOOD CELL; VASCULAR DISEASE; ANIMAL; ATHEROSCLEROSIS; DEGENERATIVE DISEASE; DIABETES MELLITUS; METABOLIC SYNDROME X; METABOLISM; NEOPLASM; OSTEOPOROSIS; PATHOLOGY;

AGING; ANIMALS; ATHEROSCLEROSIS; BIOMARKERS, TUMOR; DIABETES MELLITUS; HUMANS; METABOLIC SYNDROME; NEOPLASMS; NEURODEGENERATIVE DISEASES; OSTEOPOROSIS;

EID: 85006201188     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2016.03.005     Document Type: Article

References (79)

1. Accardi, G., Caruso, C., Colonna-Romano, G., Camarda, C., Monastero, R., Candore, G., Can Alzheimer disease be a form of type 3 diabetes?. Rejuvenation Res. 15:April (2) (2012), 217–221, 10.1089/rej.2011.1289.
2. Armulik, A., Abramsson, A., Betsholtz, C., Endothelial/pericyte interactions. Circ. Res. 97:September (6) (2005), 512–523.
3. Aronow, W.S., Fleg, J.L., Pepine, C.J., et al. ACCF/AHA 2011 expert consensus document onhypertension in the elderly: a report of the American college of cardiology foundation task force on clinical expert consensus documents developed in collaboration with the American academy of neurology, American geriatrics society, American society for preventive cardiology, American society of hypertension, American society of nephrology association of black cardiologists, and European society of hypertension. J. Am. Soc. Hypertens. 5:July–August (4) (2011), 259–352, 10.1016/j.jash.2011.06.001.
4. Balistreri, C.R., Candore, G., Accardi, G., Colonna-Romano, G., Lio, D., NF-κB pathway activators as potential ageing biomarkers: targets for new therapeutic strategies. Immun. Ageing, 10(June (1)), 2013, 24, 10.1186/1742-4933-10-24 (PubMed PMID: 23786653).
5. Balistreri, C.R., Bonfigli, A.R., Boemi, M., Olivieri, F., Ceriello, A., Genovese, S., Franceschi, C., Spazzafumo, L., Fabietti, P., Candore, G., Caruso, C., Lio, D., Testa, R., Evidences of +896A/G TLR4 polymorphism as an indicative of prevalence of complications in T2DM patients. Mediators Inflamm., 2014, 2014, 973139 (10.1155/2014/973139.).
6. Balistreri, C.R., Candore, G., Accardi, G., Buffa, S., Bulati, M., Martorana, A., Colonna-Romano, G., Lio, D., Caruso, C., Centenarian offspring: a model for understanding longevity. Curr. Vasc. Pharmacol. 12:5 (2014), 718–725.
7. Balistreri, C.R., Buffa, S., Pisano, C., Lio, D., Ruvolo, G., Mazzesi, G., Are endothelial progenitor cells the real solution for cardiovascular diseases? Focus on controversies and perspectives. Biomed. Res. Int., 2015, 2015, 835934, 10.1155/2015/835934.
8. Balistreri, C.R., Genetic contribution in sporadic thoracic aortic aneurysm? Emerging evidence of genetic variants related to TLR-4-mediated signaling pathway as risk determinants. Vascul. Pharmacol. 74:November (2015), 1–10, 10.1016/j.vph.2015.09.006.
9. Bartek, J., Hodny, Z., Ageing Old blood stem cells feel the stress. Nature 512:August (7513) (2014), 140–141, 10.1038/nature13652.
10. Beerman, I., Bhattacharya, D., Zandi, S., Sigvardsson, M., Weissman, I.L., Bryder, D., Rossi, D.J., Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc. Natl. Acad. Sci. U. S. A. 107:March (12) (2010), 5465–5470, 10.1073/pnas.1000834107.
11. Beerman, I., Bock, C., Garrison, B.S., Smith, Z.D., Gu, H., Meissner, A., Rossi, D.J., Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell. 12:April (4) (2013), 413–425, 10.1016/j.stem.2013.01.017 (Epub 2013 Feb 14).
12. Beerman, I., Seita, J., Inlay, M.A., Weissman, I.L., Rossi, D.J., Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. Cell Stem Cell. 15:July (1) (2014), 37–50, 10.1016/j.stem.2014.04.016.
13. Begus-Nahrmann, Y., Lechel, A., Obenauf, A.C., Nalapareddy, K., Peit, E., Hoffmann, E., Schlaudraff, F., Liss, B., Schirmacher, P., Kestler, H., Danenberg, E., Barker, N., Clevers, H., Speicher, M.R., Rudolph, K.L., p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat. Genet. 41:October (10) (2009), 1138–1143, 10.1038/ng.426.
14. Bonafè, M., Olivieri, F., Cavallone, L., Giovagnetti, S., Mayegiani, F., Cardelli, M., Pieri, C., Marra, M., Antonicelli, R., Lisa, R., Rizzo, M.R., Paolisso, G., Monti, D., Franceschi, C., A gender–dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur. J. Immunol. 31:August (8) (2001), 2357–2361.
15. Boudina, S., Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?. Curr. Pharm. Des. 19:32 (2013), 5684–5694.
16. Carlson, M.E., Hsu, M., Conboy, I.M., Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454 (2008), 528–532.
17. Challen, G.A., Boles, N.C., Chambers, S.M., Goodell, M.A., Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 6:March (3) (2010), 265–278, 10.1016/j.stem.2010.02.002.
18. Conboy, I.M., Conboy, M.J., Smythe, G.M., Rando, T.A., Notch-mediated restoration of regenerative potential to aged muscle. Science 302 (2003), 1575–1577.
19. Conboy, I.M., Conboy, M.J., Wagers, A.J., Girma, E.R., Weissman, I.L., Rando, T.A., Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433 (2005), 760–764.
20. Corella, D., Ordovás, J.M., Aging and cardiovascular diseases: the role of gene-diet interactions. Ageing Res. Rev. 18:November (2014), 53–73, 10.1016/j.arr.2014.08.002.
21. Dignat-George, F., Boulanger, C.M., The many faces of endothelial microparticles. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 27–33.
22. Dobaczewski, M., Akrivakis, S., Nasser, K., Michael, L.H., Entman, M.L., Frangogiannis, N.G., Vascular mural cells in healing canine myocardial infarcts. J. Histochem. Cytochem. 52:August (8) (2004), 1019–1029.
23. Dong, L.H., Lv, P., Han, M., Roles of SM22α in cellular plasticity and vascular diseases. Cardiovasc. Hematol. Disord. Drug Targets 12:December (2) (2012), 119–125.
24. Dykstra, B., Olthof, S., Schreuder, J., Ritsema, M., de Haan, G., Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J. Exp. Med. 208:December (13) (2011), 2691–2703, 10.1084/jem.20111490.
25. Felice, F., Barsotti, M.C., Poredos, P., Balbarini, A., Di Stefano, R., Effect of aging on metabolic pathways in endothelial progenitor cells. Curr. Pharm. Des. 19:13 (2013), 2351–2365.
26. Ferdinandy, P., Hausenloy, D.J., Heusch, G., Baxter, G.F., Schulz, R., Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol. Rev. 6:October (4) (2014), 1142–1174, 10.1124/pr.113.008300.
27. Ferrucci, L., Giallauria, F., Guralnik, J.M., Epidemiology of aging. Radiol. Clin. North Am. 46:July (4) (2008), 643–652, 10.1016/j.rcl.2008.07.005.
28. Flach, J., Bakker, S.T., Mohrin, M., Conroy, P.C., Pietras, E.M., Reynaud, D., Alvarez, S., Diolaiti, M.E., Ugarte, F., Forsberg, E.C., Le beau, M.M., Stohr, B.A., Méndez, J., Morrison, C.G., Passegué, E., Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 512:August (7513) (2014), 198–202, 10.1038/nature13619 (Epub 2014 Jul 30. PubMed PMID: 25079315).
29. Florian, M.C., Dörr, K., Niebel, A., Daria, D., Schrezenmeier, H., Rojewski, M., Filippi, M.D., Hasenberg, A., Gunzer, M., Scharffetter-Kochanek, K., Zheng, Y., Geiger, H., Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell 10:May (5) (2012), 520–530, 10.1016/j.stem.2012.04.007.
30. Giocanti-Auregan, A., Tadayoni, R., Ahn, L., Pena D'Amico, J.T.D.J., Mouse models of diabetic retinopathy: systematic review of the literature. J. Fr. Ophtalmol. 36:March (3) (2013), 268–276, 10.1016/j.jfo.2012.08.001.
31. Goichberg, P., Chang, J., Liao, R., Leri, A., Cardiac stem cells: biology and clinical applications. Antioxid. Redox Signal. 21:November (14) (2014), 2002–2017, 10.1089/ars.2014.5875 (Epub 2014 Apr 10).
32. Goldschmidt-Clermont, P.J., Dong, C., Seo, D.M., Velazquez, O.C., Atherosclerosis, inflammation, genetics, and stem cells: 2012 update. Curr. Atheroscler. Rep. 14:June (3) (2012), 201–210, 10.1007/s11883-012-0244-1.
33. Gulbins, H., Meiser, B.M., Reichenspurner, H., Reichart, B., Cell transplantation—a potential therapy for cardiac repair in the future?. Heart Surg. Forum. 5:4 (2002), E28–E34 (PubMed PMID: 12538127).
34. Hall, C.N., Reynell, C., Gesslein, B., Hamilton, N.B., Mishra, A., Sutherland, B.A., O'Farrell, F.M., Buchan, A.M., Lauritzen, M., Attwell, D., Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508:April (7494) (2014), 55–60, 10.1038/nature13165.
35. Hsieh, J.C., Van Den Berg, D., Kang, H., Hsieh, C.L., Lieber, M.R., Large chromosome deletions, duplications, and gene conversion events accumulate with age in normal human colon crypts. Aging Cell 12:April (2) (2013), 269–279, 10.1111/acel.12053.
36. Ito, K., Hirao, A., Arai, F., Takubo, K., Matsuoka, S., Miyamoto, K., Ohmura, M., Naka, K., Hosokawa, K., Ikeda, Y., Suda, T., Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 12:April (4) (2006), 446–451 Epub 2006 Mar 26. Erratum in: Nat. Med. 2010 Jan;16(1): 129.
37. Ivanova, E.A., Bobryshev, Y.V., Orekhov, A.N., Intimal pericytes as the second line of immune defence in atherosclerosis. World J. Cardiol. 7:October (26) (2015), 583–593, 10.4330/wjc.v7.i10.583.
38. Jaenisch, R., Young, R., Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132:4 (2008), 567–582.
39. Kim, B.O., Tian, H., Prasongsukarn, K., Wu, J., Angoulvant, D., Wnendt, S., Muhs, A., Spitkovsky, D., Li, R.K., Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 112:April (Suppl. 9) (2005), I96–104.
40. Krizhanovsky, V., Yon, M., Dickins, R.A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., Lowe, S.W., Senescence of activated stellate cells limits liver fibrosis. Cell 134:August (4) (2008), 657–667, 10.1016/j.cell.2008.06.049 (PubMed PMID: 18724938).
41. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.Y., Campisi, J., Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. U. S. A. 98 (2001), 12072–12077.
42. Li, Z., Lee, A., Huang, M., Chun, H., Chung, J., Chu, P., Hoyt, G., Yang, P., Rosenberg, J., Robbins, R.C., Wu, J.C., Imaging survival and function of transplanted cardiac resident stem cells. J. Am. Coll. Cardiol. 53:April (14) (2009), 1229–1240, 10.1016/j.jacc.2008.12.036 (PubMed PMID: 19341866).
43. Ludke, A., Li, R.K., Weisel, R.D., The rejuvenation of aged stem cells for cardiac repair. Can. J. Cardiol. 30:November (11) (2014), 1299–1306, 10.1016/j.cjca.2014.03.021 (Epub 2014 Mar 20. Review. PubMed PMID: 25092405).
44. Madonna, R., De Caterina, R., Circulating endothelial progenitor cells: do they live up to their name?. Vascul. Pharmacol. 67–69:April-June (2015), 2–5, 10.1016/j.vph.2015.02.018.
45. Madonna, R., Renna, F.V., Cellini, C., Cotellese, R., Picardi, N., Francomano, F., Innocenti, P., De Caterina, R., Age-dependent impairment of number and angiogenic potential of adipose tissue-derived progenitor cells. Eur. J. Clin. Invest. 41:February (2) (2011), 126–133, 10.1111/j.1365-2362.2010.02384.x.
46. Madonna, R., Taylor, D.A., Geng, Y.J., De Caterina, R., Shelat, H., Perin, E.C., Willerson, J.T., Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia. Circ. Res. 113:September (7) (2013), 902–914, 10.1161/CIRCRESAHA.113.301690.
47. Margariti, A., Zeng, L., Xu, Q., Stem cells, vascular smooth muscle cells and atherosclerosis. Histol. Histopathol. 21:September (9) (2006), 979–985.
48. Mazhari, R., Hare, J.M., Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat. Clin. Pract. Cardiovasc. Med. 4:Suppl. 1 (2007), S21–S26.
49. Menasché, P., Hagège, A.A., Vilquin, J.T., Desnos, M., Abergel, E., Pouzet, B., Bel, A., Sarateanu, S., Scorsin, M., Schwartz, K., Bruneval, P., Benbunan, M., Marolleau, J.P., Duboc, D., Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41:April (7) (2003), 1078–1083.
50. Minton, K., Stem cells: replication stress makes HSCs feel old. Nat. Rev. Mol. Cell Biol. 15:September (9) (2014), 560–561, 10.1038/nrm3859.
51. North, B.J., Sinclair, D.A., The intersection between aging and cardiovascular disease. Circ. Res 110:8 (2012), 1097–1108, 10.1161/CIRCRESAHA.111.246876.
52. Olivieri, F., Recchioni, R., Marcheselli, F., Abbatecola, A.M., Santini, G., Borghetti, G., Antonicelli, R., Procopio, A.D., Cellular senescence in cardiovascular diseases: potential age-related mechanisms and implications for treatment. Curr. Pharm. Des. 19:9 (2013), 1710–1719.
53. Oshima, M., Iwama, A., Epigenetics of hematopoietic stem cell aging and disease. Int. J. Hematol. 100:October (4) (2014), 326–334, 10.1007/s12185-014-1647-2.
54. Pucci, F., Gardano, L., Harrington, L., Short telomeres in ESCs lead to unstable differentiation. Cell Stem Cell 12 (2013), 479–486.
55. Rübe, C.E., Fricke, A., Widmann, T.A., Fürst, T., Madry, H., Pfreundschuh, M., Rübe, C., Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PLoS One, 6(March (3)), 2011, e17487, 10.1371/journal.pone.0017487 (PubMed PMID: 21408175).
56. Ramsay, A.J., Quesada, V., Foronda, M., Conde, L., Martínez-Trillos, A., Villamor, N., Rodríguez, D., Kwarciak, A., Garabaya, C., Gallardo, M., López-Guerra, M., López-Guillermo, A., Puente, X.S., Blasco, M.A., Campo, E., López-Otín, C., POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat. Genet. 45:May (5) (2013), 526–530, 10.1038/ng.2584.
57. Rauscher, F.M., Goldschmidt-Clermont, P.J., Davis, B.H., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108 (2003), 457–463.
58. Ren, J., Anversa, P., The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome. Biochem. Pharmacol. 93:February (4) (2015), 409–417, 10.1016/j.bcp.2014.12.006.
59. Rossi, D.J., Bryder, D., Zahn, J.M., Ahlenius, H., Sonu, R., Wagers, A.J., Weissman, I.L., Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl. Acad. Sci. U. S. A. 102:June (26) (2005), 9194–9199.
60. Rossi, D.J., Bryder, D., Seita, J., Nussenzweig, A., Hoeijmakers, J., Weissman, I.L., Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447:June (7145) (2007), 725–729 (PubMed PMID: 17554309).
61. Ruvolo, G., Pisano, C., Candore, G., Lio, D., Palmeri, C., Maresi, E., Balistreri, C.R., Can the TLR-4-mediated signaling pathway be a key inflammatory promoter for sporadic TAA?. Mediators Inflamm., 2014, 2014, 349476, 10.1155/2014/349476.
62. Saiura, A., Sata, M., Hirata, Y., Nagai, R., Makuuchi, M., Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat. Med. 7:April (4) (2001), 382–383 Erratum in: Nat. Med. 2001 May;7(5):636.
63. Schuleri, K.H., Amado, L.C., Boyle, A.J., Centola, M., Saliaris, A.P., Gutman, M.R., Hatzistergos, K.E., Oskouei, B.N., Zimmet, J.M., Young, R.G., Heldman, A.W., Lardo, A.C., Hare, J.M., Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am. J. Physiol. Heart Circ. Physiol. 294:May (5) (2008), H2002–11, 10.1152/ajpheart.00762.2007.
64. Scioli, M.G., Bielli, A., Arcuri, G., Ferlosio, A., Orlandi, A., Ageing and microvasculature. Vasc. Cell, 6, 2014, 19, 10.1186/2045-824X-6-19.eCollection2014.
65. Shimizu, F., Sano, Y., Haruki, H., Kanda, T., Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-β and vascular endothelial growth factor (VEGF) by pericytes. Diabetologia 54:June (6) (2011), 1517–1526, 10.1007/s00125-011-2107-7.
66. Smith, A.G., Embryo-derived stem cells: of mice and men. Annu. Rev. Cell Dev. Biol. 17 (2001), 435–462.
67. Song, Z., Wang, J., Guachalla, L.M., Terszowski, G., Rodewald, H.R., Ju, Z., Rudolph, K.L., Alterations of the systemic environment are the primary cause of impaired B and T lymphopoiesis in telomere-dysfunctional mice. Blood 115:8 (2010), 1481–1489, 10.1182/blood-2009-08-237230.
68. Song, Z., Zhang, J., Ju, Z., Rudolph, K.L., Telomere dysfunctional environment induces loss of quiescence and inherent impairments of hematopoietic stem cell function. Aging Cell 11 (2012), 449–455.
69. Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., Kirkland, J.L., Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Invest. 123 (2013), 966–997.
70. Urbich, C., Dimmeler, S., Endothelial progenitor cells functional characterization. Trends Cardiovasc. Med. 14 (2004), 318–322.
71. Vasilopoulos, T., Kotwal, A., Huisingh-Scheetz, M.J., Waite, L.J., McClintock, M.K., Dale, W., Comorbidity and chronic conditions in the National Social Life, Health and Aging Project (NSHAP), wave 2. J. Gerontol. B Psychol. Sci. Soc. Sci. 69:November (Suppl. 2) (2014), S154–65, 10.1093/geronb/gbu025.
72. Walne, A.J., Vulliamy, T., Beswick, R., Kirwan, M., Dokal, I., TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood 112:November (9) (2008), 3594–3600, 10.1182/blood-2008-05-153445.
73. Wang, J., Sun, Q., Morita, Y., Jiang, H., Gross, A., Lechel, A., Hildner, K., Guachalla, L.M., Gompf, A., Hartmann, D., Schambach, A., Wuestefeld, T., Dauch, D., Schrezenmeier, H., Hofmann, W.K., Nakauchi, H., Ju, Z., Kestler, H.A., Zender, L., Rudolph, K.L., A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage. Cell 148:March (5) (2012), 1001–1014, 10.1016/j.cell.2012.01.040.
74. Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., Böhm, M., Nickenig, G., Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353:September (10) (2005), 999–1007.
75. Williamson, K., Stringer, S.E., Alexander, M.Y., Endothelial progenitor cells enter the aging arena. Front. Physiol., 3, 2012, 30, 10.3389/fphys.2012.00030.eCollection2012.
76. Wojakowski, W., Landmesser, U., Bachowski, R., Jadczyk, T., Tendera, M., Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia 26:January (1) (2012), 23–33, 10.1038/leu.2011.184.
77. Yahata, T., Takanashi, T., Muguruma, Y., Ibrahim, A.A., Matsuzawa, H., Uno, T., Sheng, Y., Onizuka, M., Ito, M., Kato, S., Ando, K., Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells. Blood 118:September (11) (2011), 2941–2950, 10.1182/blood-2011-01-330050.
78. Yancik, R., Ershler, W., Satariano, W., Hazzard, W., Cohen, H.J., Ferrucci, L., Report of the national institute on aging task force on comorbidity. J. Gerontol. A Biol. Sci. Med. Sci. 62:March (3) (2007), 275–280.
79. Zeng, K., Ming, J., Yang, N., Wang, J., Yu, X., Song, Y., Yang, Y., Taurine prevents high glucose-induced angiopoietin-2/tie-2 system alterations and apoptosis in retinal microvascularpericytes. Mol. Cell Biochem. 396:November (1–2) (2014), 239–248, 10.1007/s11010-014-2159-3.